ArticleThe European respiratory journal2023

Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing.

Jay Achar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.